Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2014
11/25/2014US8895266 Antibody composition-producing cell
11/25/2014US8895263 Methods for suppressing toll-like receptor activity
11/25/2014US8895253 Integrin heterodimer and a subunit thereof
11/25/2014US8895013 Anthracycline-antibody conjugates for cancer therapy
11/25/2014US8895012 sgp130/Fc dimers
11/25/2014US8895011 Insulin-resistance-improving drug
11/25/2014US8895010 Antibody polypeptides that antagonize CD40L
11/25/2014US8895009 Purified antibody composition
11/25/2014US8895008 Compositions and methods relating to anti-IGF-1 receptor antibodies
11/25/2014US8895007 Antibodies which bind to the human CC chemokine receptor 4 and uses thereof
11/25/2014US8895005 Therapeutic agent
11/25/2014US8895001 Use of ErbB3 inhibitors in the treatment of triple negative and basal-like breast cancers
11/25/2014US8895000 Methods for inhibiting the binding of endosialin to ligands
11/25/2014US8894999 Use of DR6 and p75 antagonists to promote survival of cells of the nervous system
11/25/2014US8894998 Antibodies directed to αVβ6 and uses thereof
11/25/2014US8894997 Monoclonal antibodies to influenza H1N1 virus uses thereof
11/25/2014US8894995 Method of treating a disorder or condition of viral etiology
11/25/2014US8894990 Method for treating psoriatic arthritis by administering an anti-IL-12 antibody
11/20/2014US20140343267 Il-17 binding proteins
11/20/2014US20140343258 Novel anti-human ctgf antibody
11/20/2014US20140343257 Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
11/20/2014US20140343256 Tlr2 antagonistic antibody and use thereof
11/20/2014US20140343255 Two-stage ultrafiltration/diafiltration
11/20/2014US20140343253 Plasma protein fractionation by sequential polyacid precipitation
11/20/2014US20140343252 Interleukin-2 muteins for the expansion of t-regulatory cells
11/20/2014US20140343249 Cell killing fusion peptide exhibiting tumor cell-specific necrosis induction and tumor regression
11/20/2014US20140342450 Antibodies to ccr2
11/20/2014US20140342407 Neutralizing gp41 antibodies and their use
11/20/2014US20140342406 DNA ENCODING FUNCTION MODIFYING NAv1.7 ANTIBODIES
11/20/2014US20140342405 Vascular endothelial growth factor 2
11/20/2014US20140342404 Polypeptide variants with altered effector function
11/20/2014US20140342378 Peptides immunoreactive with autoantibodies from patients suffering from rheumatoid arthritis
11/20/2014US20140342349 Use of at least one biomarker for the in vitro prognosis or diagnosis of lymphoproliferative episodes associated with the epstein-barr virus (ebv)
11/20/2014US20140341942 Modified Streptococcus Pneumonia Pneumolysin (PLY) Polypeptides
11/20/2014US20140341929 Human binding molecules capable of binding to and neutralizing influenza b viruses and uses thereof
11/20/2014US20140341928 Stabilized Formulations Containing Anti-PCSK9 Antibodies
11/20/2014US20140341927 Antibodies and their use in the treatment, prevention and diagnosis of a disease associated with sod1 abnormalities
11/20/2014US20140341925 Formulation of human antibodies for treating tnf-alpha associated disorders
11/20/2014US20140341924 Formulation of human antibodies for treating tnf-alpha associated disorders
11/20/2014US20140341923 Human Rhinovirus (HRV) Antibodies
11/20/2014US20140341922 Method for Overcoming Tolerance to Targeted Anti-Cancer Agent
11/20/2014US20140341920 Vista modulators for diagnosis and treatment of cancer
11/20/2014US20140341919 Pharmaceutical composition for treatment and/or prevention of cancer
11/20/2014US20140341918 Vaccine for Falciparum Malaria
11/20/2014US20140341917 Anti-pd-l1 antibodies and uses thereof
11/20/2014US20140341916 Therapeutic combinations and methods of treating melanoma
11/20/2014US20140341915 B7-h6 therapeutically active monoclonal antibody against b7-h6 polypeptide
11/20/2014US20140341914 Isolated mcpip and methods of use
11/20/2014US20140341913 Methods and compositions for treating asthma using anti-il-13 antibodies
11/20/2014US20140341912 Monoclonal antibodies directed to cd52
11/20/2014US20140341911 Prevention and Treatment of Amyloidogenic Disease
11/20/2014US20140341910 Anti-human cd52 immunoglobulins
11/20/2014US20140341909 Conjugation of biomolecules using diels-alder cycloaddition
11/20/2014US20140341908 Methods and compositions to modulate antiviral and immune activity responses
11/20/2014US20140341907 Bispecific antibody fragments for neurological disease proteins and methods of use
11/20/2014US20140341906 Heterodimeric fc regions, binding molecules comprising same, and methods relating thereto
11/20/2014US20140341905 Sparc binding scfvs
11/20/2014US20140341903 Biological materials related to c-met
11/20/2014US20140341901 Compositions and methods of use for antibodies of dickkopf-1
11/20/2014US20140341899 Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
11/20/2014US20140341898 SILENT Fc VARIANTS OF ANTI-CD40 ANTIBODIES
11/20/2014US20140341896 Humanized anti-human nkg2a monoclonal antibody
11/20/2014US20140341895 PSEUDOMONAS AERUGINOSA OprM EPITOPES FOR USE IN DIAGNOSTICS AND THERAPEUTICS
11/20/2014US20140341893 Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancer
11/20/2014US20140341892 Anti-alpha2 integrin antibodies and their uses
11/20/2014US20140341891 Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
11/20/2014US20140341890 Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
11/20/2014US20140341889 Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
11/20/2014US20140341888 Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
11/20/2014US20140341887 Methods for treating, diagnosing, and monitoring rheumatoid arthritis
11/20/2014US20140341886 TREATMENT WITH ANTI ErbB2 ANTIBODIES
11/20/2014US20140341885 Formulation for anti-alpha4beta7 antibody
11/20/2014US20140341884 Novel Complex Mutations in the Epidermal Growth Factor Receptor Kinase Domain
11/20/2014US20140341883 Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
11/20/2014US20140341869 Chimeric receptors with 4-1bb stimulatory signaling domain
11/20/2014US20140341810 Antagonists for abdominal vasopressin v2 receptor and uses thereof
11/20/2014US20140341809 High-Affinity DMF5 T Cell Receptor (TCR) Variants
11/20/2014US20140341802 Provasopressin antagonists and uses thereof
11/20/2014US20140341801 Inactivation of smooth muscle tissue
11/20/2014US20140339125 Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
11/20/2014US20140339122 Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
11/18/2014US8892364 Stabilized polypeptide compositions
11/18/2014US8889847 Antibodies and immunoconjugates and uses therefor
11/18/2014US8889846 High affinity antibodies that neutralize Staphylococcus enterotoxin B
11/18/2014US8889838 Removal of serine proteases by treatment with finely divided silicon dioxide
11/18/2014US8889834 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
11/18/2014US8889833 Antibody to secreted polypeptide
11/18/2014US8889832 Antibodies inhibiting c-Met dimerization, and uses thereof
11/18/2014US8889619 Fusion protein of Exendin-4 and its analog, preparation method and use thereof
11/18/2014US8889618 C-terminal fragments of glucagon-like peptide-1 (GLP-1)
11/18/2014US8889616 MUC1 based glycolipopeptide vaccine with adjuvant
11/18/2014US8889430 Nanostructures, methods of synthesizing thereof, and methods of use thereof
11/18/2014US8889410 Mammalian cell lines for increasing longevity and protein yield from a cell culture
11/18/2014US8889389 Process for producing protein A-like protein with use of Brevibacillus genus bacterium
11/18/2014US8889376 Fusion protein binding specifically to constant region of antibody, method of preparing the fusion protein, and method of isolating antibody using the fusion protein
11/18/2014US8889363 Method for the detection and identification of a variant C. difficile strain in a sample
11/18/2014US8889145 Immunogenic compositions of Staphylococcus aureus antigens
11/18/2014US8889140 Compositions and methods for tissue repair
11/18/2014US8889138 Anti-ADDL antibodies and uses thereof
11/18/2014US8889137 Anti-HSV antibody
1 ... 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 ... 1494